VISION trial: 177Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

VISION trial: 177Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer

Published:2021 Issue:4 Volume:37 Page:372
ISSN:0970-1591
Container-title:Indian Journal of Urology
language:en
Short-container-title:Indian J Urol

Author:

Rohith Gorrepati

Publisher

Medknow

Subject

Urology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA radioligand therapy rechallenging: expanding the therapeutic possibilities in metastatic castration resistant prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-03

2. Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives;Cancers;2023-09-27

3. Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer;EJNMMI Research;2023-05-25

4. Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer;2023-03-27

5. PET/CT in Prostate Cancer;Artificial Intelligence in PET/CT Oncologic Imaging;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP